Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
- PMID: 16865310
- DOI: 10.1007/s10067-006-0356-5
Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept
Abstract
Visceral leishmaniasis (VL) is a severe disease that can develop in immunocompromised patients. Antitumor necrosis factor-alpha (TNF-alpha) treatment of rheumatoid arthritis can result in clinical benefits, but with an increased risk of opportunistic infections. Leishmania infection in patients treated with TNF-alpha antagonists is extremely rare; for this reason, we report a patient with VL after etanercept treatment who had an unfavorable outcome.
Similar articles
-
Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.J Clin Rheumatol. 2010 Mar;16(2):88-9. doi: 10.1097/RHU.0b013e3181d0bd30. J Clin Rheumatol. 2010. PMID: 20216130 No abstract available.
-
Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab.Clin Exp Rheumatol. 2005 Nov-Dec;23(6):891-2. Clin Exp Rheumatol. 2005. PMID: 16396712
-
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978. Arthritis Rheum. 2006. PMID: 16868999
-
[The pulmonological manifestations of rheumatoid arthritis].Orv Hetil. 2008 Jul 20;149(29):1355-61. doi: 10.1556/OH.2008.28385. Orv Hetil. 2008. PMID: 18617467 Review. Hungarian.
-
Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.Clin Exp Rheumatol. 2002 Sep-Oct;20(5 Suppl 27):S35-41. Clin Exp Rheumatol. 2002. PMID: 14989428 Review.
Cited by
-
Visceral leishmaniasis in immunosuppressed Caucasian patient.BMJ Case Rep. 2012 May 8;2012:bcr1120115199. doi: 10.1136/bcr.11.2011.5199. BMJ Case Rep. 2012. PMID: 22605859 Free PMC article.
-
Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum.Front Immunol. 2025 Jun 5;16:1599381. doi: 10.3389/fimmu.2025.1599381. eCollection 2025. Front Immunol. 2025. PMID: 40539059 Free PMC article.
-
New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.Drug Dev Res. 2011 Sep;72(6):451-462. doi: 10.1002/ddr.20452. Drug Dev Res. 2011. PMID: 25821334 Free PMC article.
-
Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe.Emerg Infect Dis. 2009 Jun;15(6):956-9. doi: 10.3201/eid1506.090101. Emerg Infect Dis. 2009. PMID: 19523302 Free PMC article. Review.
-
Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression.PLoS Negl Trop Dis. 2019 Aug 30;13(8):e0007708. doi: 10.1371/journal.pntd.0007708. eCollection 2019 Aug. PLoS Negl Trop Dis. 2019. PMID: 31469834 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical